Browse All
Displaying 1 - 3 of 3
Author:Vermersch, Patrick Granziera, Cristina Mao-Draayer, Yang Cutter, Gary Kalbus, Oleksandr Staikov, Ivan Dufek, Michal Montalban, Xavier Krieger, Stephen Saubadu, Stephane Luo, Xiaodong Smyth, Brendan Djukic, Biljana Truffinet, Philippe Wallstroem, Erik Giov,
Session Name:S3: Multiple Sclerosis: Clinical Trials
Topic:Multiple Sclerosis
Program Number:S3.006
Author Institution:University of Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France , Lille, France Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, Basel, Switzerland Autoimmunity Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Oklahoma City, OK Department of Biostatistics, UAB School of Public Health, Birmingham, AL, USA, Birmingham, AL Department of Neurology, Dnipro State Medical University, Dnipro, Ukraine, Dnipro, Ukraine Clinic of Neurology and Sleep Medicine, Acibadem City Clinic University Hospital Tokuda, Sofia, Bulgaria, Sofia, Bulgaria First Department of Neurology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic, Brno, Czech Republic Multiple Sclerosis Centre of Catalonia, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain , Barcelona, Spain Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, USA, New York, NY Sanofi, Gentilly, France, Gentilly, France Sanofi, Bridgewater, NJ, USA, Bridgewater, NJ Sanofi, Cambridge, MA, USA, Cambridge, MA Queen Mary University of London, London, United Kingdom , London, United Kingdom
Author:Oh, Jiwon Drulovic, Jelena Dufek, Michal Budincevic, Hrvoje Habek, Mario Caunt, Maresa Sierzega, Malgorzata Clayton, David Chen, Ying-Fang Ratchford, Jack Goodyear, Alexandra Bar-Or, Amit
Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2
Program Number:P8.005
Author Institution:St. Anne's University Hospital Brno, Teplice, Czech Republic Solmed Polyclinic and Sveti Duh University Hospital, Zagreb, Croatia University Hospital Center Zagreb, Zagreb, Croatia Genentech, Inc., South San Francisco, CA F. Hoffmann-La Roche Ltd, Basel, Switzerland University of Pennsylvania, Philadelphia, PA
Author:Stastna, Dominika Fistravec, Gregor Drahota, Jiri Menkyova, Ingrid Ampapa, Radek Potuznik, Pavel Dufek, Michal Grunermelova, Marketa Kubala Havrdova, Eva Houskova, Jana Libertinova, Jana Martinkova, Alena Pavelek, Zbysek Peterka, Marek Recmanova, Eva Rous,
Program Number:P8.009
Author Institution:Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia, Praha, Czech Republic ReMuS, The Czech Republic Multiple Sclerosis Patient Registry, Prague, Czechia, Prague, Czech Republic Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia First Department of Neurology, Masaryk University, St. Anne's University Hospital, Brno, Czechia, Teplice, Czech Republic Department of Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czechia, Praha, Czech Republic Charles University in Prague, Third Faculty of Medicine, Charles University and Hospital Kralovske Vinohrady, Prague, Czechia, Prague 10, Czech Republic Department of Neurology, Masaryk University and University Hospital Brno, Brno, Czechia, Brno, Czech Republic
